Recently, the vector nature of dissipative solitons has been exploited to demonstrate mode locked lasing with both locked and rapidly evolving states of polarisation. Here, for an erbium-doped ...

“SPiReL” is a Phase 2 non-randomized, open label, efficacy, and safety study of a novel immunotherapy combination with DPX-Survivac and pembrolizumab. Intermittent low dose cyclophosphamide is ...

Kiwi energy distributor Vector is determined to defy the "death spiral" some have forecast for network owners, aggressively pursuing new technologies such as the "internet of energy", batteries ...